News

The latest news from the pharmaceutical industry. If you have a piece of news that you would like us to cover, please contact Pippa McCartney on +44(0) 1959 563311 or email us.

AstraZeneca

AstraZeneca reaffirms December 2011 financial guidance for 2011 and mid-term planning assumptions for the 2010 to 2014 period

9 January 2012
The info was out of date planning information...

GlaxoSmithKline logo

GSK and Theravance announce initial outcomes from pivotal Phase III studies

9 January 2012
GSK and Theravance, Inc. announced the completion of the phase III registration programme...

Novartis logo

Novartis Consumer Health Inc. voluntarily recalls certain over-the-counter products in the US

8 January 2012
There have been no related adverse events reported with the issues leading to the recall...

Bristol Myers Squibb logo

Bristol-Myers Squibb to acquire Inhibitex

7 January 2012
Bristol-Myers Squibb to acquire Inhibitex for $26.00 per share in cash pursuant to a cash tender offer and second step merger...

Zósimo López Moreno, GEA Pharma Systems

New Director Sales and Business Development for GEA Pharma Systems in Latin America

6 January 2012
GEA Pharma Systems has appointed Zósimo López Moreno...

Merck logo

FDA approves Merck’s ISENTRESS® (raltegravir)

6 January 2012
The U.S. FDA recently approved the use of ISENTRESS® (raltegravir) in combination with other antiretroviral (ARV) medicines...

Gilead logo

Gilead Sciences announces early termination of Hart-Scott-Rodino waiting period

6 January 2012
Gilead Sciences, Inc. has received early termination of the required waiting period...

Merck-Millipore-logo-60x60

Merck Millipore collaborates with Peking University

5 January 2012
Merck Millipore, announced that the division was invited to serve on the faculty of the CPIER at Peking University...

Biogen Idec logo

Biogen Idec and Isis Pharmaceuticals announce global collaboration

4 January 2012
Biogen Idec and Isis Pharmaceuticals, Inc. have entered into an exclusive, worldwide option and collaboration agreement...

Astellas_Logo

Tivozanib demonstrated superiority over sorafenib in patients with advanced renal cell cancer in Phase 3 TIVO-1 trial

4 January 2012
Tivozanib has demonstrated superiority over sorafenib...

TEVA_LOGO

Advanced magnetic resonance imaging technology suggests axonal repair in MS patients treated with COPAXONE®

3 January 2012
Study findings published in Frontiers in Bioscience...

H. Lundbeck A/S Logo 60x60

Onfi™ (clobazam) tablets now available in the US at retail pharmacies

3 January 2012
Lundbeck announced that Onfi tablets are now available for prescribing in the United States...